Abstract purple and blue undulating waves

Deterministic, auditable decision systems in healthcare and enterprise.

PHIIR Labs is a research and development company advancing data-driven systems that transform how organizations interpret, decide, and deliver.

Our focus lies at the intersection of business intelligence, healthcare precision, and regulatory integrity — creating technologies that solve complex problems in critical environments.

We design software that converts uncertainty into structured insight - enabling faster, safer, and more accurate decisions. Every product under PHIIR Labs shares a unique principle: rigorous logic applied to real-world failure.

Our Goal

We aim to create deterministic, reviewable, and human-centered systems that bring order to complex decision environments.

person holding black and white round ornament
person holding black and white round ornament

About PHIIR Labs

Deterministic intelligence for the real world.

Our Current Programs

PHIIR Labs is developing two deterministic systems addressing critical failure points in healthcare and enterprise decision-making.

D.A.N.A. — Dose Accuracy & Notification Assistant

Developer: PHIIR Labs 
Category: Class IIb SaMD — Medication Safety & Verification

D.A.N.A. is a clinical verification system in active development for hospital medication workflows. It validates dose accuracy in real time, strengthens compliance auditing, and maintains a secure digital record of medication administration — supporting clinicians in delivering safer care within regulated environments.

Focus Areas

  • Clinical dose verification

  • Medication workflow integration

  • Compliance and audit automation

Positioning
D.A.N.A. aims to reduce preventable medication errors and reinforce institutional accountability as digital-health and safety mandates evolve globally.

Development Status
Currently in pre-clinical validation and regulatory readiness testing.
Partner institutions are being identified for early evaluation and workflow integration.

Register institutional interest for hospitals and governance teams seeking participation in early pilot programmes.

Kevpin Signals

Developer: PHIIR Labs 
Category: Data-Intelligence Systems — Decision Control & Enterprise Performance Signals

Kevpin Signals is an applied-intelligence system in advanced development under PHIIR Labs. It functions as a decision control layer, allowing organisations to test strategies before execution.

Kevpin Signals expose the conditions that typically precede success or failure — enabling leadership teams to make faster, evidence-based, and more auditable decisions.

Focus Areas

  • Decision premortem analysis

  • Strategic risk and performance modelling

  • Data governance and interpretability frameworks

Positioning
Kevpin Signals gives enterprises a measurable edge in forecast precision, decision-cycle speed, and capital-allocation efficiency — turning hindsight into foresight through disciplined, testable intelligence.

Development Status
Currently in controlled private trials with selected research and enterprise partners.
Public release to follow final validation of model stability and interpretability.

Request a confidential briefing — for strategic, research, or investment partners interested in early evaluation of the Kevpin Signals decision-control framework.

D.A.N.A by PHIIR Labs is investigational software under development and not yet available for clinical use.

Validation & Collaboration

Our team at PHIIR Labs design, test, and validate our systems with partners who value transparency, regulatory alignment, and measurable outcomes.

Our validation framework includes:

  • Defined endpoints — safety, precision, and workflow fit.

  • Ethical review and data-governance compliance at pilot stage.

  • Human-overridable systems, reviewed for explainability and traceability.

  • Publication-ready documentation built alongside development.

We are currently forming pilot collaborations in the United Kingdom, United States, and Canada.

→ Interested in partnering with us or reviewing a pilot brief?